Invention Grant
US08637530B2 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
有权
8-（3-氨基 - 哌啶-1-基） - 黄嘌呤，它们的制备及其作为药物的用途
- Patent Title: 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
- Patent Title (中): 8-（3-氨基 - 哌啶-1-基） - 黄嘌呤，它们的制备及其作为药物的用途
-
Application No.: US13346234Application Date: 2012-01-09
-
Publication No.: US08637530B2Publication Date: 2014-01-28
- Inventor: Waldemar Pfrengle , Peter Sieger
- Applicant: Waldemar Pfrengle , Peter Sieger
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Timothy X. Witkowski
- Priority: DE102005035891 20050730
- Main IPC: A61K31/522
- IPC: A61K31/522 ; C07D473/04 ; A61P3/10 ; A61P3/04
Abstract:
The invention relates to 8-[3-amino-piperidin-1-yl]-xanthines and the physiologically acceptable salts thereof, particularly the hydrochlorides thereof.
Public/Granted literature
- US20120142712A1 8-(3-AMINO-PIPERIDIN-1-YL)-XANTHINES, THEIR PREPARATION, AND THEIR USE AS PHARMACEUTICALS Public/Granted day:2012-06-07
Information query
IPC分类:
